Drug Chatter -- Tracking biopharma stock chatter

Profile for Pluristem Therapeutics, Inc. (PSTI)

« Back to company index

PSTI Chatter Timeline

Stock Ticker for PSTI

Most Active Tweeters for PSTI

UserTweets
@GantosJ 6
@TickerReport 4
@SleekMoneycom 4
@WeekHerald 4
@WatchlistN 3

Recent Tweets for PSTI

ledgerzette @ledgerzette
Pluristem Therapeutics, Inc. $PSTI Given a $3.00 Price Target by Maxim Group Analysts https://t.co/nrETd74PQy
November 16th 2017, 7:11pm
GantosJ @GantosJ
$PSTI nice reversal candlestick, bouncing back while RSI & Stochasrtics reversal & out from the Over-Sold territori… https://t.co/ZM6614OhHG
November 16th 2017, 5:11pm
WKRBNews @WKRBNews
Pluristem Therapeutics, Inc. $PSTI Issues Quarterly Earnings Results, Hits Expectations https://t.co/NWAOJNamej
November 16th 2017, 8:11am
dailymailtimes @dailymailtimes
Pluristem Therapeutics, Inc. $PSTI Issues Quarterly Earnings Results, Hits Expectations https://t.co/wqgwPwdyVp
November 16th 2017, 8:11am
dailypoliticaln @dailypoliticaln
Pluristem Therapeutics, Inc. $PSTI Issues Quarterly Earnings Results, Hits Expectations https://t.co/QdD0P4f2Qb
November 16th 2017, 8:11am
midetimes @midetimes
Pluristem Therapeutics, Inc. $PSTI Issues Quarterly Earnings Results, Hits Expectations https://t.co/HUu6uUrcS3
November 16th 2017, 8:11am
GantosJ @GantosJ
Interesting comment in PSTI's Q1 Fiscal 2018 Corporate and Financial Highlights! $PSTI seen a burgeoning interest i… https://t.co/K8Mi6ppSW9
November 16th 2017, 8:11am
dakotafinancial @dakotafinancial
Pluristem Therapeutics, Inc. $PSTI Sees Significant Growth in Short Interest https://t.co/garm8J7R6F
November 16th 2017, 5:11am
GantosJ @GantosJ
$PSTI 13 out of 14 clinical sites already recruiting patients in the CLI-Critical Limb Ischemia Ph3 trial (Estimate… https://t.co/qwiPYlPuJz
November 15th 2017, 2:11pm
ledgerzette @ledgerzette
Pluristem Therapeutics, Inc. $PSTI Given Average Rating of “Hold” by Brokerages https://t.co/6Z4sq6mF0R
November 15th 2017, 12:11am
bdailystocks @bdailystocks
$PSTI $1.43 -0.03 (-2.05%)- News Out on Pluristem Therapeutics https://t.co/guLkSzGu3y
November 14th 2017, 10:11pm
hotpennyalerts @hotpennyalerts
$PSTI 's Numbers Revealed https://t.co/QKwQ7NiG5x
November 14th 2017, 8:11pm
btstocks @btstocks
$PSTI First Quarter Fiscal 2018 Corporate and Financial Highlights https://t.co/Kwmq6dj4zC
November 14th 2017, 8:11am
TickerReport @TickerReport
Pluristem Therapeutics, Inc. $PSTI Posts Quarterly Earnings Results https://t.co/XTlaulynxk
November 14th 2017, 7:11am
emq_news @emq_news
Pluristem Therapeutics, Inc. $PSTI Posts Quarterly Earnings Results https://t.co/bUVVGT9nzU
November 14th 2017, 7:11am
TickerReport @TickerReport
Pluristem Therapeutics, Inc. $PSTI Posts Quarterly Earnings Results https://t.co/3JYPfcCJBV
November 14th 2017, 7:11am
intercooleronli @intercooleronli
Pluristem Therapeutics, Inc. $PSTI Announces Earnings Results https://t.co/1gzjnHiZxU
November 14th 2017, 7:11am
CFinancialNews @CFinancialNews
Pluristem Therapeutics, Inc. $PSTI Announces Earnings Results https://t.co/XKvpQomaic
November 14th 2017, 7:11am
AmericanBanking @AmericanBanking
Pluristem Therapeutics, Inc. $PSTI Announces Earnings Results https://t.co/Y6itTyp5fi
November 14th 2017, 7:11am
WatchlistN @WatchlistN
Pluristem Therapeutics, Inc. $PSTI Announces Earnings Results https://t.co/qCyy22ZCkV
November 14th 2017, 7:11am
wlstcom @wlstcom
Pluristem Therapeutics reports Q1 results #premarket #PSTI #PluristemTherapeutics,Inc. $PSTI https://t.co/S6DviI426U https://t.co/TQI9PNqidq
November 14th 2017, 7:11am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Pluristem Therapeutics reports Q1 results https://t.co/cKxsoIjbYP #premarket $PSTI
November 14th 2017, 7:11am
MarketCurrents @MarketCurrents
Pluristem Therapeutics reports Q1 results https://t.co/jt3MZADBaZ #premarket $PSTI
November 14th 2017, 7:11am
stockboardinc @stockboardinc
$PSTI Pluristem Reports First Quarter Fiscal 2018 Corporate and Financial Highlights... - https://t.co/UQQoO7HYrL
November 14th 2017, 7:11am
AmericanBanking @AmericanBanking
Pluristem Therapeutics Gets Average Rating of Hold from Analysts $PSTI https://t.co/FaNzh7JLPe
November 14th 2017, 7:11am
GNWLive @GNWLive
Pluristem Reports First Quarter Fiscal 2018 Corporate and Financial Highlights $PSTI https://t.co/Mox0Ca6WKt
November 14th 2017, 7:11am
ZolmaxNews @ZolmaxNews
Pluristem Therapeutics $PSTI Getting Somewhat Favorable Press Coverage, Accern Reports https://t.co/qK5iV7TSy1
November 14th 2017, 2:11am
BlastarTrader @BlastarTrader
Is It Time To Buy Pluristem Therapeutics Inc $PSTI ? https://t.co/2blgAtgPb5
November 13th 2017, 11:11am
ITipsDaily @ITipsDaily
$ARGS $PSTI two more tickers added to my pre-market mover's list this morning. Also I'm still watching this week… https://t.co/DnsqEWkwyg
November 13th 2017, 8:11am
WeekHerald @WeekHerald
Head-To-Head Comparison: Pluristem Therapeutics $PSTI versus Its Competitors https://t.co/1zQ66pX0NT
November 13th 2017, 3:11am
storminvestor @storminvestor
Pluristem Therapeutics’ $PSTI Buy Rating Reiterated at HC Wainwright https://t.co/Pcx2MUWMmN
November 12th 2017, 5:11pm
SPNewsAnalysis @SPNewsAnalysis
Pluristem Therapeutics’ $PSTI Buy Rating Reiterated at HC Wainwright https://t.co/ciq6PkOWhv
November 12th 2017, 5:11pm
noritsunagirota @noritsunagirota
Pluristem Therapeutics Inc. $PSTI EPS Estimated At $-0.08 https://t.co/Kgyh7X57zj
November 12th 2017, 5:11am
SleekMoneycom @SleekMoneycom
Pluristem Therapeutics, Inc. $PSTI Stock Rating Reaffirmed by HC Wainwright https://t.co/6tMlXTsYUz
November 11th 2017, 8:11pm
TheMarketsDaily @TheMarketsDaily
Pluristem Therapeutics, Inc. $PSTI Stock Rating Reaffirmed by HC Wainwright https://t.co/dXx9GryYPP
November 11th 2017, 7:11pm
storminvestor @storminvestor
Pluristem Therapeutics, Inc. $PSTI Given Buy Rating at HC Wainwright https://t.co/uQCsfsIHNK
November 11th 2017, 7:11pm
WeekHerald @WeekHerald
Pluristem Therapeutics, Inc. $PSTI Given Buy Rating at HC Wainwright https://t.co/t84gsIcBBA
November 11th 2017, 7:11pm
SleekMoneycom @SleekMoneycom
Maxim Group Analysts Give Pluristem Therapeutics, Inc. $PSTI a $3.00 Price Target https://t.co/HKz6Pf3sLE
November 11th 2017, 4:11pm
SleekMoneycom @SleekMoneycom
Head-To-Head Comparison: Pluristem Therapeutics $PSTI vs. Its Competitors https://t.co/nNi01iJjct
November 11th 2017, 9:11am
MarginHunt @MarginHunt
Our Pluristem Therapeutics $PSTI valuation models imply upside b4 earnings Monday https://t.co/sjmECbeP9z
November 10th 2017, 6:11pm
PKnox26 @PKnox26
I really recommend everyone check this out for finding good stocks to trade https://t.co/N8NijIhUIP $PSTI $PLPM… https://t.co/Ei5jfjR75r
November 9th 2017, 9:11pm
lritchie25 @lritchie25
RT @GantosJ: $PSTI Full technical correction & volume decrease, time for a bounce back, forming a "Bullish Hammer" that might become a reve…
November 9th 2017, 3:11pm
GantosJ @GantosJ
$PSTI Full technical correction & volume decrease, time for a bounce back, forming a "Bullish Hammer" that might be… https://t.co/qKhNui3YkS
November 9th 2017, 3:11pm
dakotafinancial @dakotafinancial
Pluristem Therapeutics’ $PSTI Buy Rating Reaffirmed at HC Wainwright https://t.co/r44DUK4xGk
November 9th 2017, 1:11pm
ConsumerFeed @ConsumerFeed
Pluristem Therapeutics’ $PSTI Buy Rating Reaffirmed at HC Wainwright https://t.co/phKwQil1VW
November 9th 2017, 1:11pm
RatingsNetwork @RatingsNetwork
Pluristem Therapeutics's buy rating reiterated at HC Wainwright. $3.50 PT. https://t.co/lwTH0lSNmK $PSTI #PSTI
November 9th 2017, 1:11pm
dispatchtribune @dispatchtribune
Pluristem Therapeutics $PSTI & Its Competitors Head to Head Review https://t.co/Ni3rw3bGo3
November 9th 2017, 8:11am
StockTipRobot @StockTipRobot
The probability of this advice being random is high. Still, hold on to Pluristem Therapeutics $PSTI #ProTip
November 7th 2017, 11:11pm
TickerReport @TickerReport
Pluristem Therapeutics, Inc. $PSTI Given Consensus Recommendation of “Hold” by Analysts https://t.co/YPKdvSzxkx
November 7th 2017, 10:11pm
emq_news @emq_news
Pluristem Therapeutics, Inc. $PSTI Given Consensus Recommendation of “Hold” by Analysts https://t.co/ce36etnsVX
November 7th 2017, 10:11pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.